Flavia Mangone

Dr. Flavia Mangone

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 March 2024 in Journal of the Endocrine Society
Verified
Journal Article
Open access
PDF file
LCLuciana Audi Castroneves
Luciana Audi Castroneves
FMFlavia Mangone
Flavia Mangone
ALAntonio Marcondes Lerario
Antonio Marcondes Lerario
AMAna Maria da Cunha Mercante
Ana Maria da Cunha Mercante
RBRAFAEL LOCH BATISTA
RAFAEL LOCH BATISTA
AHAna Oliveira Hoff
Ana Oliveira Hoff
Context Genetic analysis of sporadic medullary thyroid carcinoma (MTC) has revealed somatic variants in RET, RAS, and occasionally other genes. However, around 20% of patients with sporadic MTC lack a known genetic driver. Objective To uncover potential new somatic or germline drivers, we analyze a distinct cohort of patients with sporadic, very early–onset, and aggressive MTC. Methods Germline and somatic DNA exome sequencing was performed in 19 patients, previously tested negative for germline RET variants. Results Exome sequencing of 19 germline samples confirmed the absence of RET and identified an NF1 pathogenic variant in 1 patient. Somatic sequencing was successful in 15 tumors revealing RET variants in 80%, predominantly p.Met918Thr, which was associated with disease aggressiveness. In RET-negative tumors, pathogenic variants were found in HRAS and NF1. The NF1 germline and somatic variants were observed in a patient without a prior clinical diagnosis of neurofibromatosis type 1, demonstrating that the loss of heterozygosity of NF1 functions as a potential MTC driver. Somatic copy number alterations analysis revealed chromosomal alterations in 53.3% of tumors, predominantly in RET-positive cases, with losses in chromosomes 9 and 22 being the most prevalent. Conclusion This study reveals that within a cohort of early-onset nonhereditary MTC, RET remains the major driver gene. In RET-negative tumors, NF1 and RAS are drivers of sporadic MTC. In addition, in young patients without a RET germline mutation, a careful clinical evaluation with a consideration of germline NF1 gene analysis is ideal to exclude Neurofibromatosis type 1 (NF1).

12 November 2020 in Biomarkers in Medicine
Verified
Journal Article
Closed access
FMFlavia Mangone
Flavia Mangone
MVMaira Av Valoyes
Maira Av Valoyes
RNRenan G Do Nascimento
Renan G Do Nascimento
MCMércia Pf Conceição
Mércia Pf Conceição
DBDaniel R Bastos
Daniel R Bastos
MNMaria Nagai
Maria Nagai
Aim: The PHLDA (pleckstrin homology like domain, family A) gene family encodes proteins capable of inhibiting AKT (serine/threonine kinase) signaling through phosphoinositol binding competition. Re...

1 January 2024 in Brazilian Journal of Medical and Biological Research
Verified
Journal Article
Open access
PDF file
CFCaroline Faria
Caroline Faria
CBCamila Machado Baldavira
Camila Machado Baldavira
FMFlavia Mangone
Flavia Mangone
MAM.E.M. Agati
M.E.M. Agati
LKLeslie Kulikowski
Leslie Kulikowski
LAL. Antonangelo
L. Antonangelo
Personalized therapy in lung cancer (LC) has revolutionized routine histopathology and cytopathology, emphasizing the importance of obtaining adequate material for molecular studies to support oncological decisions. Adaptations of cytologic sample preparations offer benefits for molecular testing, yet their potential remains underutilized. A significant number of LC cases is identified through specimens of aspiration or exfoliative cytology. Improving screening approaches and optimizing tissue utilization for biomarker research are crucial for effective LC management. The utilization of formalin-fixed, paraffin-embedded (FFPE) tumor tissues has become standard practice in clinical and epidemiological genetic research. However, current techniques require not only a standardized sample fixation and storage but also sufficient genetic material to yield reliable results. In this study, we utilized the Qiagen GeneRead® DNA FFPE kit with an adapted protocol for two extraction methods: one involved cutting FFPE blocks and the other involved scraping tissue from slides used for histochemical and cytological analysis. Our findings emphasized the importance of increasing the number of FFPE sections, heat deparaffinization, and adjusting proteinase K digestion time to enhance genomic DNA (gDNA) yields. Notably, scraping tissue from slides yielded superior results compared to the standard FFPE protocol. A median of 2.82 and 4.34 DNA yields for tumor and lymph node, respectively, were obtained. Our results demonstrated the feasibility of this adapted protocol for gDNA extraction in clinical and epidemiological studies. We recommend scraping tissue from slides as a reliable source of gDNA and suggest fine-tuning proteinase K digestion time and heat exposure based on the input tissue volume.

29 June 2021 in Genes
Verified
Journal Article
Open access
PDF file
APAna Carolina Pavanelli
Ana Carolina Pavanelli
FMFlavia Mangone
Flavia Mangone
LBLuciana Rodrigues Carvalho Barros
Luciana Rodrigues Carvalho Barros
Juliana Machado-RugoloJuliana Machado-Rugolo
Juliana Machado-Rugolo
VERA CAPELOZZIVERA CAPELOZZI
VERA CAPELOZZI
MNMaria Nagai
Maria Nagai
Abnormal long non-coding RNAs (lncRNAs) expression has been documented to have oncogene or tumor suppressor functions in the development and progression of cancer, emerging as promising independent biomarkers for molecular cancer stratification and patients’ prognosis. Examining the relationship between lncRNAs and the survival rates in malignancies creates new scenarios for precision medicine and targeted therapy. Breast cancer (BRCA) is a heterogeneous malignancy. Despite advances in its molecular classification, there are still gaps to explain in its multifaceted presentations and a substantial lack of biomarkers that can better predict patients’ prognosis in response to different therapeutic strategies. Here, we performed a re-analysis of gene expression data generated using cDNA microarrays in a previous study of our group, aiming to identify differentially expressed lncRNAs (DELncRNAs) with a potential predictive value for response to treatment with taxanes in breast cancer patients. Results revealed 157 DELncRNAs (90 up- and 67 down-regulated). We validated these new biomarkers as having prognostic and predictive value for breast cancer using in silico analysis in public databases. Data from TCGA showed that compared to normal tissue, MIAT was up-regulated, while KCNQ1OT1, LOC100270804, and FLJ10038 were down-regulated in breast tumor tissues. KCNQ1OT1, LOC100270804, and FLJ10038 median levels were found to be significantly higher in the luminal subtype. The ROC plotter platform results showed that reduced expression of these three DElncRNAs was associated with breast cancer patients who did not respond to taxane treatment. Kaplan–Meier survival analysis revealed that a lower expression of the selected lncRNAs was significantly associated with worse relapse-free survival (RFS) in breast cancer patients. Further validation of the expression of these DELncRNAs might be helpful to better tailor breast cancer prognosis and treatment.

1 November 2021 in Toxicology
Verified
Journal Article
Closed access
JBJôse Mára de Brito
Jôse Mára de Brito
Francine AlmeidaFrancine Almeida
Francine Almeida
FAFernanda Magalhães Arantes-Costa
Fernanda Magalhães Arantes-Costa
EGEliane Tigre Guimarães
Eliane Tigre Guimarães
AMAdriana Morgan
Adriana Morgan
TMTHAIS MAUAD
THAIS MAUAD

24 June 2024 in Einstein (São Paulo)
Verified
Journal Article
Open access
PDF file
CFCaroline Faria
Caroline Faria
CBCamila Machado Baldavira
Camila Machado Baldavira
FMFlavia Mangone
Flavia Mangone
MNMaria Nagai
Maria Nagai
VFViviane Rossi Figueiredo
Viviane Rossi Figueiredo
LALeila Antonangelo
Leila Antonangelo
Category: Thoracic Oncology Introduction: Genomic mutational profiling, obtained through next-generation sequencing (NGS) plays a pivotal role in assisting clinicians in therapeutic decision- making in patients with non-small cell cancer (NSCLC).(,) However, these techniques require high quality and sufficient quantity of material to produce reliable results.(,) Our study proposes the use of tissue scraping from histological and cytological slides as an alternative method for obtaining genomic DNA (gDNA) of better quality and quantity, and also an optimized extraction protocol from paraffin